3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Response Shift-Adjusted Treatment Effect on Health-Related Quality of Life in a Randomized Controlled Trial of Taxane Versus S-1 for Metastatic Breast Cancer: Structural Equation Modeling.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We investigated the quantification of the response shift-adjusted treatment effect on quality-of-life (QOL) data in a randomized controlled trial of taxane versus S-1 for patients with metastatic breast cancer (SELECT-BC).

          Related collections

          Author and article information

          Journal
          Value Health
          Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
          Elsevier BV
          1524-4733
          1098-3015
          June 2020
          : 23
          : 6
          Affiliations
          [1 ] Department of Oral Implantology, Osaka Dental University, Hirakata, Japan; CRECON Medical Assessment, Inc, Tokyo, Japan. Electronic address: tatsunori.murata@crecon.jp.
          [2 ] Department of Physical Medicine and Rehabilitation, Tohoku University Graduate School of Medicine, Sendai, Japan.
          [3 ] Department of Health and Welfare Services, National Institute of Public Health, Saitama, Japan.
          [4 ] Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
          [5 ] Department of Biomedical Sciences, Ritsumeikan University, Kusatsu, Shiga, Japan.
          [6 ] Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
          [7 ] Division of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
          Article
          S1098-3015(20)30129-7
          10.1016/j.jval.2020.02.003
          32540235
          77d2877a-edc3-4143-801b-92064be3d744
          Copyright © 2020 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.
          History

          breast cancer,chemotherapy,quality of life,response shift,structural equation modeling

          Comments

          Comment on this article